Additionally, MCPH1/BRIT1 is an inclusion eligibility criterion in 2 clinical trials for squamous cell lung carcinoma, 3 clinical trials for non-small cell lung carcinoma, and 5 clinical trials for small cell lung carcinoma (72). The gene discussed is MCPH1; the disease is squamous cell lung carcinoma.